Diabetes puts myocardial n-3 fatty acid status at risk in the absence of supplementation in the rat

Lipids

Volumn 34, Issue 1, 1999, Pages

  McLennan, P L ^a   Raederstorff, D ^a,b  

^a CSIRO   (Australia)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; FATTY ACID METABOLISM; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE METABOLISM; LIPID COMPOSITION; MALE; NONHUMAN; RAT;

EID: 0033000891     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02562242     Document Type: Conference Paper

References (4)

1. Fein, F.S. (1996) Clinical Manifestations of Diabetic Cardiomyopathy, in Chatham, J.C. Forder, J.R., and McNeill, J.H. (eds.) The Heart in Diabetes. (Kluwer, Dortrect, Netherlands). Developments in Cardiovascular Med. 185, 1-22.
2. Daviglus, M.L., Stamler, J., Orencia, A.J., et al. (1997) Fish Consumption and the 30-year Risk of Fatal Myocardial Infarction, N. Eng. J. Med. 336, 1046-1053.
3. Faas, F.H., and Carter, W.J. (1980) Altered Fatty Acid Desaturation and Microsomal Fatty Acid Composition in the Streptozotocin Diabetic Rat, Lipids 15, 953-961.
4. McLennan, P.L. (1992) Relative Effects of Dietary Saturated Monounsaturated and Polyunsaturated Fatty Acids on Cardiac Arrhythmias in the Rat. Am. J. Clin. Nutr. 57, 207-212.